Identificação
Identificação pessoal
- Nome completo
- Ana Preto
Nomes de citação
- Preto, Ana
- Preto A
- Ana Preto
Identificadores de autor
- Ciência ID
- C81F-9F8C-1790
- ORCID iD
- 0000-0002-7302-0630
- Google Scholar ID
- https://scholar.google.pt/citations?user=9AEIAW0AAAAJ&hl=en
- Researcher Id
- H-8112-2012
- Scopus Author Id
- 6602508305
Endereços de correio eletrónico
- apreto@bio.uminho.pt (Profissional)
Telefones
- Fax
-
- 253678980 (Profissional)
- Telefone
-
- 253601524 (Profissional)
Moradas
- Departamento de Biologia, Escola de Ciências, Universidade do Minho. Campus de Gualtar, 4710-057, Braga, Braga, Portugal (Profissional)
Websites
- https://cbma.uminho.pt/people-detail/?userid=17 (Profissional)
Domínios de atuação
- Ciências Naturais - Ciências Biológicas - Biologia Celular
Idiomas
Idioma | Conversação | Leitura | Escrita | Compreensão | Peer-review |
---|---|---|---|---|---|
Inglês | Utilizador proficiente (C1) | Utilizador proficiente (C1) | Utilizador proficiente (C1) | Utilizador proficiente (C1) | |
Francês | Utilizador proficiente (C1) | Utilizador proficiente (C1) | Utilizador independente (B1) | Utilizador proficiente (C1) | |
Espanhol; Castelhano | Utilizador proficiente (C1) | Utilizador proficiente (C1) | Utilizador independente (B1) | Utilizador proficiente (C1) | |
Português | Utilizador proficiente (C1) | Utilizador proficiente (C1) | Utilizador proficiente (C1) | Utilizador proficiente (C1) |
Formação
Grau | Classificação | |
---|---|---|
2000/07 - 2004/01
Concluído
|
PhD in Human Biology (Doutoramento)
Especialização em GABBA
Universidade do Porto Faculdade de Medicina, Portugal
"Identification of potential mechanisms of tolerance to wild-type p53 in human carcinogenesis using thyroid neoplasia as a
prototype" (TESE/DISSERTAÇÃO)
|
Maximum classification (unanimously) |
1992/09 - 1998/07
Concluído
|
Bachelor degree in Pharmaceutical Sciences (Licenciatura)
Universidade do Porto Faculdade de Farmácia, Portugal
|
15/20 values |
Percurso profissional
Ciência
Categoria Profissional Instituição de acolhimento |
Empregador | |
---|---|---|
2007 - Atual | Investigador visitante (Investigação) | Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal |
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal | ||
2007 - Atual | Investigador principal (carreira) (Investigação) | Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal |
Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal | ||
2004 - 2007 | Pós-doutorado (Investigação) | Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal |
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal |
Docência no Ensino Superior
Categoria Profissional Instituição de acolhimento |
Empregador | |
---|---|---|
2007 - Atual | Professor Auxiliar (Docente Universitário) | Universidade do Minho Departamento de Biologia, Portugal |
Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal | ||
2018/04/02 - 2018/04/23 | Professor Visitante (Docente Universitário) | Brunel University London - Institute of Environment, Health and Societies, College of Health and Life Sciences, Reino Unido |
Brunel University London - Institute of Environment, Health and Societies, College of Health and Life Sciences, Reino Unido | ||
2007 - 2009 | Professor Auxiliar Convidado (Docente Universitário) | Universidade do Minho Departamento de Biologia, Portugal |
Universidade do Minho Departamento de Biologia, Portugal | ||
2004 - 2007 | Professor Auxiliar Convidado (Docente Universitário) | Instituto Superior de Saúde, Portugal |
Instituto Superior de Saúde, Portugal |
Cargos e Funções
Categoria Profissional Instituição de acolhimento |
Empregador | |
---|---|---|
2021 - Atual | Member of the Scientific Council of ECUM | Universidade do Minho, Portugal |
Universidade do Minho Escola de Ciências, Portugal | ||
2021 - 2023 | Director of the Bachelor in Biochemistry | Universidade do Minho, Portugal |
Universidade do Minho Departamento de Biologia, Portugal | ||
2021 - 2023 | Member of the Pedagogical Council of ECUM | Universidade do Minho Escola de Ciências, Portugal |
Universidade do Minho Escola de Ciências, Portugal | ||
2018 - 2023 | Member of the Management Team of Associação Portuguesa de Investigação em Cancro (ASPIC) | Associação Portuguesa de Investigação em Cancro (ASPIC), Portugal |
Associação Portuguesa de Investigação em Cancro (ASPIC), Portugal | ||
2013 - 2020 | Responsible Pharmaceutical (professional license nº 10931) at INFARMED for lmport, management and conservation of Narcotics / Psychotropic Substances | Ordem dos Farmaceuticos, Portugal |
Ordem dos Farmaceuticos, Portugal | ||
2015 - 2017 | Member of the Committee of the Master's in Molecular Genetics | Universidade do Minho, Portugal |
Universidade do Minho Departamento de Biologia, Portugal | ||
2013 - 2016 | Member of the Scientific Committee of the Doctoral Program in Molecular and Environmental Biology | Universidade do Minho, Portugal |
Universidade do Minho Departamento de Biologia, Portugal | ||
2013 - 2015 | Director of the Master's Degree in Molecular Genetics | Universidade do Minho, Portugal |
Universidade do Minho Departamento de Biologia, Portugal | ||
2013 - 2015 | Member of the ECUM Pedagogical Council | Universidade do Minho, Portugal |
Universidade do Minho Escola de Ciências, Portugal | ||
2011 - 2013 | Member of the Applied Biology Course Committee, coordinator of the 1st academic year | Universidade do Minho, Portugal |
Universidade do Minho Departamento de Biologia, Portugal | ||
2010 - 2013 | Coordinator of the CBMA research area: Molecular targets for human diseases | Universidade do Minho, Portugal |
Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal | ||
2010 - 2012 | Member of the Quality Committee of the Scientific Council of the Department of Biology | Universidade do Minho, Portugal |
Universidade do Minho Departamento de Biologia, Portugal |
Projetos
Bolsa
Designação | Financiadores | |
---|---|---|
2018 - 2018 | Sabbatical grant under the Program IACOBUS
IACOBUS
Sabbatical grant
|
|
2004 - 2007 | Potential mechanisms of tolerance to wild-type p53 in human tumours using differentiated thyroid carcinoma as a prototype
SFRH/BPD/14882/2003
Bolseiro de Pós-Doutoramento
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
1999 - 2003 | Identification of potential mechanisms of tolerance to wild-type p53 in human carcinogenesis using thyroid neoplasia as a
prototype
PRAXIS XXI/BD/21795/99
Bolseiro de Doutoramento
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
1998 - 1999 | Identification of biological markers of diagnosis and prognosis in thyroid carcinomas, using differential display technique
PRAXIS XXI/BIC/17133/98
Bolseiro de Iniciação Científica
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
1998 - 1999 | Identification of biological markers of diagnosis and prognosis in thyroid carcinomas, using differential display technique
PRAXIS XXI/BIC/17133/98
|
Fundação para a Ciência e a Tecnologia |
Projeto
Designação | Financiadores | |
---|---|---|
2022 - Atual | Programa Pessoa 2022-2023 Agreement between Portugal and France- 2021.09253.CBM- "BAXREG: In vivo and in vitro approaches
towards the elucidation of Bax regulation mechanisms by N-terminal acetylation and by interaction with the KRAS oncogene"
2021.09253.CBM
Investigador
Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal
|
Fundação para a Ciência e a Tecnologia
Em curso
|
2019 - Atual | CBMA's Strategic Project as a Center of Excellence
UID/BIA/04050/2019
Integrated membership
Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal
|
Fundação para a Ciência e a Tecnologia
Em curso
|
2018 - 2021 | Lead4Target - Fighting metastatic cancers: prime time for ruthenium
PTDC/QUI-QIN/28662/2017
Investigador responsável
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento, Portugal Associação para a Investigação e Desenvolvimento da Faculdade de Medicina, Portugal Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal |
Fundação para a Ciência e a Tecnologia
Em curso
|
2018 - 2021 | The other faces of telomerase: looking beyond tumor immortalization
PTDC/MED-ONC/31438/2017
Investigador
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
2016 - 2019 | EcoAgriFood - Innovative green products and processes to promote Agri-Food BioEconomy
NORTE-45-2015-02
Investigador
Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal
|
União Europeia - Portugal 2020 - Norte 2020
Concluído
|
2015 - 2017 | CBMA's strategic project as a Center of Excellence
UID/BIA/04050/2013
Integrated membership
Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
2013 - 2016 | Phosphobax - Phosphoregulation of Bax-dependent cell death
FCT-ANR/BEX-BCM/0175/2012
Investigador
Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
2013 - 2016 | GLYCOPHARM - The Sugar Code: from bio(chemical) concept to clinics
FP7-PEOPLE-2012-ITN
Investigador
Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal
|
Marie Curie
Concluído
|
2009 - 2013 | NANOFOL - Folate-based nanobiodevices for integrated diagnosis/therapy targeting chronic inflammatory diseases
FP7 NMP-2008-4.0-1
Investigador
Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal
|
União Europeia
Concluído
|
2009/01/01 - 2012/06/30 | Elucidation of ceramide-induced apoptosis: modulation of Protein Kinase C isoforms
PTDC/BIA-BCM/69448/2006
Investigador
Universidade do Minho Departamento de Biologia, Portugal
Universidade do Minho, Portugal Universidade do Porto Faculdade de Farmácia, Portugal Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal |
Fundação para a Ciência e a Tecnologia
Concluído
|
2005 - 2008 | BRAF and KRAS mutations in mismatch repair deficiency colon cancer. New prognostic and therapeutic tool?
POCTI/SAU-OBS/56921/2004
Investigador
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia |
2005 - 2008 | Oncogenic role of BRAF activation in thyroid carcinogenesis.
POCTI/SAU-OBS/56175/2004
Investigador
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
2005 - 2008 | In mismatch repair deficiency colorectal cancer are BRAF and KRAS new prognostic and therapeutic tools?
Investigador
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
2005 - 2008 | In vitro studies of compounds with putative anti-oxidant activity, obtained from medicinal plants traditionally used in Portugal
Anti-oxidant - UNICER
Investigador
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
UNICER
Concluído
|
2003/07/01 - 2008 | Potential mechanisms of tolerance to wild-type p53 in human tumours using differentiated thyroid carcinoma as a prototype.
Investigador
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia |
2004 - 2007 | Role of raft domains in the modulation/alteration of the transducing pathways in normal thyroid and in papillary thyroid carcinoma
PTCRIS: 48171
Investigador
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
2006 - 2006 | Biological role of BRAF activation in colon carcinogenesis. STI-571/Gleevec as a therapeutic agent?
STI-571/Gleevec
Investigador responsável
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Novartis AG
Concluído
|
2004 - 2006 | Biological role of BRAF oncogene activation in human carcinogenesis. Use of BAY 43-9006 as a BRAF inhibitor agent?
BAY 43-9006
Investigador responsável
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Bayer Portugal SA
Concluído
|
1995 - 1998 | Identification of biological markers of diagnosis and prognosis in thyroid carcinomas, using differential display technique
PRAXIS XXI/2/2.1/SAU/1187/95
Investigador
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
Fundação para a Ciência e a Tecnologia |
Produções
Publicações
Artigo em conferência |
|
Artigo em revista |
|
Artigo em revista (magazine) |
|
Capítulo de livro |
|
Poster em conferência |
|
Resumo em conferência |
|
Tese / Dissertação |
|
Propriedade Intelectual
Patente |
|
Atividades
Apresentação oral de trabalho
Título da apresentação | Nome do evento Anfitrião (Local do evento) |
|
---|---|---|
2023/03/31 | “Microbiota-derived short-chain fatty acids disturb cell survival and glycolytic metabolism: new strategy to fight colorectal cancer.” | India|EMBO Lecture Course on “Tumour metabolism: Current understanding and opportunities for novel drug discovery”
EMBO (Noida, Índia)
|
2022/09/20 | “Specific Targeting for Colorectal Cancer Harbouring KRAS Mutation Using a New Ruthenium-Based Agent”. | 6th Cancer World Congress
Cancer World Congress (Lisboa, Portugal)
|
2021/11 | New ruthenium-cyclopentadienyl agents as a new strategy to fight colorectal cancer | 7th International Electronic Conference on Medicinal Chemistry
(Basel, Suiça)
|
2021/11 | The potential of novel benzo[a]phenoxazine derivatives for colorectal cancer treatment | 7th International Electronic Conference on Medicinal Chemistry
(Basel, Suiça)
|
2021/08 | Antifungal properties and NIR fluorescent staining of cells with benzo[a]phenoxazinium chlorides having a sulfonamide group | Virtual Conference on Chemistry and its Applications |
2021 | How yeast and cancer cells link-up to study colorectal cancer | Palestra por convite na Unidade Curricular: BASES MOLECULARES DO CANCRO E PRINCÍPIOS TERAPÊUTICOS
Universidade do Minho, Escola de Medicina (Braga, Portugal)
|
2020/01 | Fighting Breast Cancer with Ruthenium-based Metallodrugs endowed with Tumor-targeting Vectors | 13º Encontro Nacional de Química Orgânica/ 6º Encontro Nacional de Química Terapêutica
Universidade de Aveiro (Aveiro, Portugal)
|
2019 | New Ruthenium-Cyclopentadienyl Complexes Bearing Biotinylated (Macro)Ligands: Targeting Strategies To Fight Metastatic Breast Cancer | 6th Young Medicinal Chemist Symposium |
2019 | Strategies for targeted cancer therapy using ruthenium-cyclopentadienyl complexes | 3rd International Caparica Christmas Congress on Translational Chemistry 2019 |
2018/12/06 | The role of diet related short chain fatty acid acetate in colorectal cancer | Conferences in Oncobiology
Universidade do Porto, Faculdade de Farmácia (Porto, Portugal)
|
2018/11 | The role of diet related short chain fatty acid acetate in colorectal cancer: prevention and therapeutic implications | International workshop NO-CANCER 2018: Understanding Cancer Cell Biology to improve Diagnosis and Therapy
(Novara, Itália)
|
2018/05/30 | How yeast and cancer cells meet as a tool to identify new molecular targets for colorectal cancer | Seminário por convite
Centro de Investigaciones Biomedicas (CINBIO), University of Vigo (Vigo, Espanha)
|
2018/05/09 | How yeast and cancer cells meet as a tool to identify new molecular targets for colorectal cancer | Seminário por convite
Centro de Química Estrutural (CEQUIM), Faculdade de Ciências, Universidade de Lisboa (Lisboa, Portugal)
|
2018/04/19 | How yeast and cancer cells meet as a tool to identify new molecular targets for colorectal cancer | Seminário por convite - Biosciences seminar
University of Brunel (Londres, Reino Unido)
|
2018 | Novel ruthenium cyclopentadienyl complexes bearing bipyridine based (macro)ligands with strong activity towards cancer cells | 4th European Conference on Smart Inorganic Polymers |
2018 | On the mode of action of anticancer ruthenium-polymer conjugates | International Conference on Coordination Chemistry |
2018 | Unveil the KRAS/Galectin-3/p16INK4a triple axis regulation in colorectal cancer | Porto Cancer Meeting |
2017/11/22 | How yeast and cancer cells join to understand the role of KRAS in autophagy | DBio Seminar
Universidade do Minho, Departamento de Biologia
|
2017/04/27 | Cancer definition and hallmarks | Curso de Pós-Graduação ONCOBIOLOGY
CESPU
|
2017/02/02 | Telomerase and cancer | ONCOBIOLOGY, Programa GABBA
IPATIMUP (Porto, Portugal)
|
2017 | Mitochondrial ROS accumulation sensitizes colorectal cancer cells to acetate and cathepsin D inhibitors combination therapy | MitoPorto – Advances in Mitochondrial Research |
2017 | Cancer targeted therapy: the next generation of metallodrugs | 18th International Conference on Biological Inorganic Chemistry |
2016/05/02 | Cancer definition and hallmarks | Curso de Pós-Graduação ONCOBIOLOGY
CESPU
|
2016 | Transport of monocarboxylic acids in cancer cells: implications of short chain fatty acids and 3-bromopyruvate for cancer therapy | 34th Small meeting on yeast transport and energetics |
2016 | Targeting cancer with new multifunctional metallodrugs | World Conference on Cancer Research and Therapy
(Miami, Estados Unidos)
|
2016 | Transport of short chain fatty acids and 3-bromopyruvate in cancer cells: implications for cancer therapy | Sociedade Portuguesa de Bioquimica |
2016 | New molecular targets and therapeutic approaches for colorectal cancer | XVII Jornadas de Biologia Aplicada
Universidade do Minho, Departamento de Biologia
|
2016 | Unravel the impact of mutant KRAS alleles on autophagy regulation in colorectal cancer | DBio Seminar
Universidade do Minho, Departamento de Biologia
|
2015/09/23 | Unveil the role of mutated KRAS signaling in colorectal carcinoma: towards identification of new molecular targets | Curso de Pós-Graduação - GlycoBiology SUMMER SCHOOL
Universidade do Minho, Departamento de Biologia
|
2015 | On the mode of action of new promising anticancer agents: multifunctional polymer-ruthenium conjugates | 4th International Conference on Medicinal Chemistry & Computer Aided Drug Designing
(Atlanta, Estados Unidos)
|
2015 | Multifunctional polymer-ruthenium cyclopentadienyl complexes: new promising anticancer agents | I International Caparica Christmas Congress on Translational Chemistry
(Caparica, Portugal)
|
2015 | Colon cancer-related mutant KRAS alleles function as positive regulators of autophagy | IMYA |
2014 | Characterization of 3-bromopyruvate uptake in breast cancer cells | 4th Annual Meeting of the International Society of Proton Dynamics in Cancer |
2014 | The yeast vacuolar protease Pep4p unveils a novel function of the human Cathepsin D during acetate-induced mitochondrial apoptosis in colorectal carcinoma cells | IMYA X INTERNATIONAL MEETING ON YEAST APOPTOSIS |
2014 | Characterization of peptides as a membrane anchor in liposomes for the incorporation of ligands for specific targeting | 8th International Conference on Polymer and Fiber Biotechnology |
2014 | Yeast and mammalian cells as complementary models to identify new molecular targets for colorectal carcinoma | II AEICBAS Biomedical Congress
Universidade do Porto
|
2014 | Cell signaling: Signal Transduction in Cancer | Fundamentals of Genetics, Development and Neoplasia” com o titulo
ICVS
|
2013 | New peptide-linker of folate-target liposomes for specific drug delivery | 246th ACS Meeting |
2013 | Characterization of 3-bromopyruvate uptake in breast cancer cells | 4th Annual Meeting of the International Society of Proton Dynamics in Cancer |
2013 | Novel therapeutic approaches for colorectal cancer: the role of small chain fatty acids and oncogene KRAS | Ciência Falada
ICVS
|
2012 | Liposomal formulations for specific drug delivery | 243th ACS |
2012 | Discovering messenger RNA and micro RNA expression patterns in normal, greying hair | European Hair Research Society |
2012 | NANOFOL: Nanobiodispositivos com folato para diagnóstico/terapêutica integrados de doenças crónicas inflamatórias | workshop “Ciência & Engenharia: Investigação e inovação para o desenvolvimento sustentável" |
2011 | What yeast can tell us about how cells commit suicide? | 14th Portugaliae Genetica |
2011 | Vacuole-mitochondrial crosstalk during acetic acid-induced yeast apoptosis | 8th International Meeting on Yeast Apoptosis |
2011 | Monocarboxylate transporters – new molecular targets for colorectal carcinoma? | Zing Cancer Conference 2011: from carcinogenesis to cancer therapy |
2010 | A yeast heterologous expression system to understand the role of human oncogene KRAS in autophagy regulation | Jornadas Portuguesas de Genética
Universidade do Minho
|
2010 | Know your body to control it: a journey from basic science to nanotechnology | I Jornadas de Bioquímica |
2008 | KRAS and BRAF mutations in colorectal cancer progression | Porto Cancer meeting |
2007 | Novas terapêuticas no carcinoma da tireóide: efeito biológico da inibição farmacológica de cinases em linhas celulares do carcinoma da tireóide | Tumores endócrinos-7º simpósio nacional |
2007 | Sensitivity of thyroid cancer cells to BAY 43-9006 is distinct from BRAF specific inhibition. Biological and therapeutic implications | 1st Iberic Meeting on Medical Chemistry-Anticancer Agents |
2007 | MAP kinase signalling pathway in gastrointestinal cancer | 1st Iberic Meeting on Medical Chemistry-Anticancer Agents |
2007 | Proliferação e agentes anti-proliferativos no tratamento do cancro | Colóquios 2007 para Professores do Liceu
IPATIMUP (Porto, Portugal)
|
2004 | Biological effects of kinase inhibition in thyroid cancer cell lines using a pharmacological approach | Thyroid meeting
IPATIMUP (Porto, Portugal)
|
2003 | P53 mediated growth arrest in response to telomere erosion is retained in a subset of human cancer cell lines | 1º Congresso da Sociedade Portuguesa de Ciências Farmacêuticas |
2003 | P53 mediated growth arrest in response to telomere erosion is retained in a subset of human cancer cell lines | European Thyroid Association Annual Meeting |
2002 | p63 in Solid cell nests:further evidence for a stem cell origin | XXIVth International Congress of the International Academy of Pathology |
Orientação
Título / Tema Papel desempenhado |
Curso (Tipo) Instituição / Organização |
|
---|---|---|
2019 - Atual | New ruthenium-based anticancer agents: promising therapeutic approach towards colorectal cancer
Orientador
|
Molecular and Environmental Biology (Doutoramento)
Universidade do Minho, Portugal
|
2019 - Atual | Uncover the role of KRAS/Galectin-3 loop in the crosstalk between colorectal cancer cells and tumor-associated macrophages:
therapeutic implications
Orientador
|
Doctoral Program in Molecular and Environmental Biology (Doutoramento)
Universidade do Minho, Portugal
|
2023 - 2024 | The role of microbiota-derived short-chain fatty acids in extracellular vesicles production by colorectal cancer
Orientador de Daniela Oliveira Macedo
|
Biophysics and Bionanosystems (Mestrado)
Universidade do Minho, Portugal
|
2023 - 2024 | Unravelling the anticancer effect of a new ruthenium-agent targeting KRAS mutation in pancreatic cancer
Orientador de Cláudia Matos da Costa
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2023 - 2024 | Exploring the effect of a new ruthenium-agent targeting KRAS mutation in pancreatic cancer using in vitro and in vivo models
Orientador de Ana Cristina Ferreira Moreira
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2023 - 2024 | Anticancer effects of postbiotics in colorectal and pancreatic cancer
Orientador de Vanessa Alejandra Bernardo Rodriguez
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2022 - 2023 | “Uncover the mechanism of action of new FeCp compounds in colorectal cancer cells”
Orientador
|
Biologia Celular e Molecular (Mestrado)
Universidade do Porto Faculdade de Ciências, Portugal
|
2022 - 2023 | Short-chain fatty acids as potential modulators of new ruthenium anticancer drug in colorectal cancer therapy
Orientador de Renata Filipe Oliveira Matos
|
Applied Biochemistry (Mestrado)
Universidade do Minho, Portugal
|
2018 - 2023 | The role of Bcl-2 protein family and Beclin-1 in KRAS-mediated regulation of apoptosis/autophagy using yeast and colorectal
cancer as models.
Coorientador
|
Molecular and Environmental Biology (Doutoramento)
Universidade do Minho, Portugal
|
2018 - 2023 | Unveiling the role of diet microbiome-derived short chain fatty acids in prevention and therapy of colorectal cancer using
a colon-on-a-chip model
Orientador
|
Molecular and Environmental Biology (Doutoramento)
Universidade do Minho, Portugal
|
2017 - 2023 | Uncovering all death induction mechanisms and anti-cancer properties of novel benzo[a]phenoxazine derivatives
Coorientador
|
Molecular and Environmental Biology (Doutoramento)
Universidade do Minho, Portugal
|
2020 - 2021 | Supervisor of Catarina Teixeira with a junior researcher grant as part of the project Lead4Target: Fighting metastatic cancers:
prime time for ruthenium; PTDC/QUI-QIN/28662/2017
Orientador
|
Universidade do Minho, Portugal
|
2014 - 2020 | Metabolic remodelling of colorectal carcinoma: crosstalk between lactate transport and oncogenic signalling
Coorientador
|
Health Sciences (Doutoramento)
Universidade do Minho, Portugal
|
2019 - 2019 | Toxicity assessment of products for the agri-food sector potentially implicated in human wellbeing
Orientador
|
Applied Biochemistry (Mestrado)
Universidade do Minho, Portugal
|
2019 - 2019 | Elucidating the role of the Coxsackie and Adenovirus Receptor (CAR) in regulating AKT signaling and glucose metabolism in
cancer and inflammation
Coorientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2019 - 2019 | The role of CXCR4 in cancer exosomes and metastasis
Coorientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2019 - 2019 | The role of aberrant glycosylation of CD44 in gastrointestinal carcinoma and its application for cancer biomarker purposes
Coorientador
|
Applied Biochemistry (Mestrado)
Universidade do Minho, Portugal
|
2019 - 2019 | Exploring the anticancer effect of new ruthenium-biotinylated conjugates in colorectal cancer
Orientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2019 - 2019 | Toxicity assessment of combinations of food contaminants and additives potentially implicated in human wellbeing
Orientador
|
Applied Biochemistry (Mestrado)
Universidade do Minho, Portugal
|
2018/07 - 2018/12 | Research project RuPMC (IF/01302/2013)
Coorientador
|
Universidade do Minho, Portugal
|
2018 - 2018 | The role of oncogenic KRAS in colorectal cancer: from subcellular localization upon autophagy induction to new therapeutic
drugs”
Orientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2018 - 2018 | Unraveling the molecular targets of new ruthenium-based anticancer drugs
Orientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2018 - 2018 | Understanding the role of KRAS hotspot mutations in KRAS/Galectin-3/p16INK4a axis regulation in colorectal cancer
Orientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2018 - 2018 | Uncovering the role of acetate in the crosstalk between monocarboxylate transportes and oncogene signalling pathways in colorectal
cancer
Orientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2018 - 2018 | Unveil the role of actin on KRAS induced autophagy in colorectal cancer, using Caenorhabditis elegans as an "in vivo" model
Orientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2017 - 2017 | Study the roles of human galectin-3 using the yeast saccharomyces cerevisiae and colorectal cancer cells as eukaryotic models
Coorientador
|
Molecular and Environmental Biology (Doutoramento)
Universidade do Minho, Portugal
|
2017 - 2017 | Understanding the role of oncogenic KRAS mutations in the regulation of mitochondria metabolism and Bax-mediated cell death.
Coorientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2017 - 2017 | Impact of immune blockade receptor PD-1 in p53wt tumor cells
Coorientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2017 - 2017 | Characterization of the Nuclear and Inner Neclear Membrane Proteome of Mammalian Cells
Coorientador
|
Applied Biochemistry (Mestrado)
Universidade do Minho, Portugal
|
2016 - 2016 | The role of macroH2A1 in prostate carcinogenesis
Coorientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2016 - 2016 | Development of a non-invasive approach for oral squamous cell carcinoma diagnosis
Coorientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2016 - 2016 | Researching novel proteins involved with aneuploidy
Coorientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2016 - 2016 | Exploring the anticancer effects of multifunctional polymer-ruthenium conjugates
Orientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2015/03 - 2015/09 | Co-supervisor of the research grant holder Rita Francisco as part of the RuPMC research project (IF/01302/2013), funded by
FCT in collaboration with the lead researcher Andreia Valente from Faculdade de Ciências da Universidade Lisboa.
Coorientador
|
Universidade do Minho, Portugal
|
2015 - 2015 | Development of new DODAX:MO:DC-Chol nanoparticles containing BRAF-siRNA for colorectal cancer therapy
Orientador
|
Biophysics and Bionanosystems (Mestrado)
Universidade do Minho, Portugal
|
2015 - 2015 | Development of an improved propionibacterium for potencial use as a nutraceutical towards the prevention/treatment of colorectal
cancer
Orientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2015 - 2015 | 3-Bromopiruvato uma droga anti-cancro com múltiplos alvos: das bases moleculares as futuras aplicações clinicas
Orientador
|
Biochemistry (Licenciatura/Bacharelato)
Universidade do Minho, Portugal
|
2015 - 2015 | O papel do feedback loop do oncogene KRAS-p16INK4a no cancro colorretal
Orientador
|
Applied Biology (Licenciatura/Bacharelato)
Universidade do Minho, Portugal
|
2014 - 2015 | Co-supervisor of the post-doctoral fellow Sara Cristina Sequeira Alves within the project FCT-ANR/BEX-BCM/0175/2012 in cooperation
with France (University of Bordeaux 2): Phosphoregulation of Bax-dependent cell death (Phosphobax).
Coorientador
|
Universidade do Minho, Portugal
|
2014 - 2014 | 3-Bromopyruvate as an anticancer agent in breast cancer cell lines: exploring the role of monocarboxylate transporters
Coorientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2014 - 2014 | Understanding the role of KRAS-regulated autophagy in colorectal cancer: therapeutic implications
Orientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2014 - 2014 | Exploring galectin-3/KRASmut/p16ink4a interplay in colorectal cancer
Orientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2014 - 2014 | The physiology and biochemistry of Methylacidiphilum fumariolicum SoIV
Coorientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2014 - 2014 | Effects of increasing allostatic load in stress physiology of Sea bass (Dicentrarchus labrax L.) and Sea bream (Sparus aurata
L.)
Coorientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2014 - 2014 | Understanding the role of KRAS mutations in mitochondria regulation in the yeast model
Coorientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2014 - 2014 | Study of antitumor and immunomodulatory activities of wild mushroom extracts
Coorientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2014 - 2014 | The role of KRAS and ceramide pathways in autophagy regulation towards understanding its role in colorectal carcinoma
Orientador
|
Molecular and Environmental Biology (Doutoramento)
Universidade do Minho, Portugal
|
2013 - 2013 | Current overview of the role of short-chain fatty acids in prevention or therapy of colorectal carcinoma
Orientador
|
Sciences - Continuous Professor Training (Mestrado)
Universidade do Minho, Portugal
|
2013 - 2013 | The role of monocarboxylate transporters in 3-bromopyruvate effect in cancer cells
Coorientador
|
Molecular and Environmental Biology (Doutoramento)
Universidade do Minho, Portugal
|
2013 - 2013 | Impact of mutated KRAS signalling on autophagy regulation in colorectal carcinoma
Orientador
|
Molecular and Environmental Biology (Doutoramento)
Universidade do Minho, Portugal
|
2013 - 2013 | Acoplamento de BSA e benzo[a]fenoxazinas a nanopartículas de CdSe/ZnS para desenvolvimento de biossensores de atividade redox
Coorientador
|
Applied Biology (Licenciatura/Bacharelato)
Universidade do Minho, Portugal
|
2013 - 2013 | Reverting HOXA9-mediated Resistance to Temozolomide Chemotherapy in Brain Tumors
Coorientador
|
Applied Biology (Licenciatura/Bacharelato)
Universidade do Minho, Portugal
|
2013 - 2013 | Study the role of propionate in the survival of colorectal carcinoma cells harbouring different oncogenic mutations
Orientador
|
Biochemistry (Licenciatura/Bacharelato)
Universidade do Minho, Portugal
|
2012 - 2012 | The role of KRAS mutations signalling in autophagy control in colorectal carcinomas
Orientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2012 - 2012 | Study the Role of Ceramide in Acetic Acid Induced Cell Death in Colorectal Carcinoma Cell Lines
Orientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2012 - 2012 | Study the role of RAF-1 in MAPK signaling in thyroid cancer cells
Orientador
|
Biotechnology for the Health Sciences (Mestrado)
Universidade de Trás-os-Montes e Alto Douro, Portugal
|
2012 - 2012 | The role of ceramide in response to acetic acid induced cell death in colorectal carcinoma derived cell lines
Orientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2012 - 2012 | Somitogenesis molecular clock
Coorientador
|
Applied Biology (Licenciatura/Bacharelato)
Universidade do Minho, Portugal
|
2012 - 2012 | Role of embryonic macrophages in lung vascular development
Coorientador
|
Applied Biology (Licenciatura/Bacharelato)
Universidade do Minho, Portugal
|
2012 - 2012 | O efeito do 3-bromopiruvato (3BP) como inibidor metabólico no tratamento de cancro
Coorientador
|
Applied Biology (Licenciatura/Bacharelato)
Universidade do Minho, Portugal
|
2012 - 2012 | Protein Microspheres as Templates for anti-cancer drugs delivery
Orientador
|
Applied Biology (Licenciatura/Bacharelato)
Universidade do Minho, Portugal
|
2011 - 2011 | Unraveling the mechanisms involved in acetate induced apoptosis in colorectal cancer
Orientador
|
Pathology and Molecular Genetics (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2011 - 2011 | Development of folate-targeted liposomes for rheumatoid arthritis therapy
Orientador
|
Molecular and Environmental Biology (Doutoramento)
Universidade do Minho, Portugal
|
2011 - 2011 | Role of monocarboxylate transporters in colorectal carcinoma
Coorientador
|
Health Sciences (Mestrado)
Universidade do Minho, Portugal
|
2011 - 2011 | Influência da sobre-expressão da HOXA9 na resposta celular à quimioterapia
Orientador
|
Applied Biology (Licenciatura/Bacharelato)
Universidade do Minho, Portugal
|
2011 - 2011 | Regulação da Expressão do Receptor de Androgénios na Próstata de Rato
Orientador
|
Applied Biology (Licenciatura/Bacharelato)
Universidade do Minho, Portugal
|
2010 - 2010 | Study the response to acetate in colorectal carcinoma cells harbouring different genetic background: the role of the lysosome
Orientador
|
Biotechnology for the Health Sciences (Mestrado)
Universidade de Trás-os-Montes e Alto Douro, Portugal
|
2010 - 2010 | Study the effect of synthetic Tamoxifen-like compounds in survival of cancer cells
Coorientador
|
Biotechnology for the Health Sciences (Mestrado)
Universidade de Trás-os-Montes e Alto Douro, Portugal
|
2010 - 2010 | Caracterização molecular da Displasia Arritmogénica Ventricular Direita em pacientes com suspeita clínica da doença: uma abordagem
de diagnostico molecular mais rápida e económica
Orientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2010 - 2010 | Estudo anatomopatológico em cérebros de ratinhos transgénicos para a Doença de Machado-Joseph
Orientador
|
Applied Biology (Licenciatura/Bacharelato)
Universidade do Minho, Portugal
|
2010 - 2010 | Bioactive anticancer compounds produced by marine sponges. What about Portuguese reality?
Coorientador
|
Biology/Geology (Licenciatura/Bacharelato)
Universidade do Minho, Portugal
|
2009 - 2009 | Autophagy regulation by RAS towards understanding its role in human cancer
Orientador
|
Molecular Genetics (Mestrado)
Universidade do Minho, Portugal
|
2009 - 2009 | Caracterização mutacional do gene ATP1A2em doentes com Enxaqueca Hemiplégica Familiar (FHM)
Orientador
|
Applied Biology (Licenciatura/Bacharelato)
Universidade do Minho, Portugal
|
2008 - 2008 | Optimização da separação e identificação de glicoproteínas de soro humano de indivíduos com cancro
Orientador
|
Applied Biology (Licenciatura/Bacharelato)
Universidade do Minho, Portugal
|
2008 - 2008 | The role of autophagy in colorectal carcinomas. The cross-talk of RAS and Beclin-1 pathways
Orientador
|
Applied Biology (Licenciatura/Bacharelato)
Universidade do Minho, Portugal
|
2008 - 2008 | Capillary treatments with oligonucleotides
Orientador
|
Applied Biology (Licenciatura/Bacharelato)
Universidade do Minho, Portugal
|
2005 - 2007 | Biological role of BRAF activation in colon carcinogenesis. STI-571/Gleevec as a therapeutic agent
Orientador
|
Universidade do Minho, Portugal
|
2005 - 2007 | Potential mechanisms of tolerance to wild-type p53 in human tumours using thyroid as a prototype
Orientador
|
Universidade do Minho, Portugal
|
2004 - 2005 | Biological role of BRAF activation in colon carcinogenesis. STI-571/Gleevec as a therapeutic agent
Orientador
|
|
2003 - 2004 | Potential mechanisms of tolerance to wild-type p53 in human tumours using thyroid as a prototype
Coorientador
|
Universidade do Minho, Portugal
|
Organização de evento
Nome do evento Tipo de evento (Tipo de participação) |
Instituição / Organização | |
---|---|---|
2013 - Atual | Organizer and coordinator of the Advanced course Cancer therapy: from basic research to clinic, Departamento de Biologia da
Universidade do Minho. (2013)
Outro (Presidente da Comissão Organizadora)
|
Universidade do Minho, Portugal |
2022/09/28 - 2022/09/30 | Member of the Organising Committee of the 6th Cancer World Congress, Lisbon, Portugal.
(2022/09/28 - 2022/09/30)
Congresso (Membro da Comissão Organizadora)
|
|
2022/06/30 - 2022/07/01 | Member of the Organising Committee of the Conference "5th ASPIC International Congress" (2022/06/30)
Conferência (Membro da Comissão Organizadora)
|
Associação Portuguesa de Investigação em Cancro, Portugal |
2021 - 2021 | Member of the Organizing Committee of the II ASPIC-ASEICA International Meeting Current Trends in Precision Medicine in Cancer,
online event (2021)
Encontro (Membro da Comissão Organizadora)
|
Associação Portuguesa de Investigação em Cancro (ASPIC), Portugal |
2020/03/02 - 2020/03/04 | Member of the Organizing Committee of the EACR-AACR-ASPIC Conference: Tumor Microenvironment, Lisbon, Portugal. (2020)
Conferência
|
Associação Portuguesa de Investigação em Cancro (ASPIC), Portugal |
2019/12/19 - 2019/12/20 | - Member of the organizing committee of the I Symposium on Biophysics and Bionanosystems, which marked the 10th edition of
the Master's Degree in Biophysics and Bionanosystems. Braga. (2019 - 2019)
Simpósio (Membro da Comissão Organizadora)
|
Universidade do Minho, Portugal |
2019/10/17 - 2019/10/19 | President of the organization of the international congress ISCAM 2019 - 6th Annual Meeting, Bom Jesus de Braga, Braga. (2019/10/17 - 2019/10/19)
Congresso (Presidente da Comissão Organizadora)
|
International Society of Cancer Metabolism, Portugal |
2018/10/26 - 2018/10/26 | Member of the Organizing Committee of the ASPIC Conference - Colorectal cancer in Portugal: from research to prevention and
treatment, Auditorium Mariano Gago of i3S, Porto. (2018/10/26 - 2018/10/26)
Conferência (Membro da Comissão Organizadora)
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal |
2016/04/28 - 2016/04/29 | - Member of the organizing committee and poster session chair of the 2nd International Congress of Associação Portuguesa de
Investigação em Cancro (ASPIC), April 28-29, 2016, IPO, Porto, Portugal (2016 - 2016)
Congresso (Membro da Comissão Organizadora)
|
Associação Portuguesa de Investigação em Cancro (ASPIC), Portugal |
Júri de grau académico
Tema Tipo de participação |
Nome do candidato (Tipo de grau) Instituição / Organização |
|
---|---|---|
2022/12/19 | "Unravelling the role of cell metabolism in the molecular mechanisms of resistance in cancer. Encapsulation of glycolytic
inhibitors in nanoparticles to increase their release in a lung cancer model."
Arguente principal
|
Andrea Teixeira da Cunha (Doutoramento)
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2022/11/18 | Main evaluator of the probationary year report and the development of the work leading to the Doctoral Thesis of Master Sofia Manuela Moreira Dias, with the title: "3D-CRCol: 3D ColoRectal Cancer spheroid model with a 3D cOLon model for drug and nanoparticle safety and efficacy screening" | Sofia Manuela Moreira Dias (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2022/06/17 | Main evaluator of the report of the probationary year and of the development of the work leading to the PhD Thesis of Master Eleonora Secomandi, with the title: "High Expression of Lysosomal Cathepsin D Inhibits Neuroblastoma Cell Growth, Migration and Invasion, and Confers Better Prognosis in Neuroblastoma Patients" | Eleonora Secomandi (Doutoramento)
Università degli Studi del Piemonte Orientale Amedeo Avogadro - Sede di Novara, Itália
|
2021/06/07 | Panel Member of the Doctoral Thesis of Diana Isabel Pereira Guimarães: "Development of liposomal formulations for therapeutic
applications". PhD in Chemical and Biological Engineering.
Arguente
|
Diana Isabel Pereira Guimarães (Doutoramento)
Universidade do Minho Escola de Engenharia, Portugal
|
2021/06/06 | Panel Member of the Doctoral Thesis of Cristiana Filipa Chaves Costa: "Development of new strategies to model the shape of
hair from the follicle". PhD in Chemical and Biological Engineering.
Arguente
|
Cristiana Filipa Chaves Costa (Doutoramento)
Universidade do Minho Escola de Engenharia, Portugal
|
2021 | Effect of the microenvironment on alternative splicing in colorectal cells
Arguente principal
|
Joana Filipa de Sousa Pereira (Doutoramento)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
2021 | m6ACODE: Deciphering the hidden message in m6A methylation in Gastric Cancer
Arguente principal
|
Diana Cristina Silva Ferreira de título (Mestrado)
Universidade do Porto Faculdade de Medicina, Portugal
|
2021 | Deciphering the functional role of KRAS-induced SUSD2 downregulation in colorectal cancer
Arguente principal
|
Diogo Rafael Dias Coelho (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2020 | Studying the combined effect of Pirfenidone and Vinorelbine in lung and breast cancer cell lines
Arguente principal
|
Catarina Teixeira Antunes (Mestrado)
Universidade do Porto Faculdade de Medicina, Portugal
|
2020 | The Immunomodulation Potential of Pancreatic Cancer Exosomes
Arguente principal
|
Sofia Torres Ferrando Alves Quintas (Mestrado)
Universidade do Porto Faculdade de Medicina, Portugal
|
2020 | Melanoma in zebrafish disregards Telomere Maintenance Mechanisms
Arguente principal
|
Joana Nabais (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2020 | New Biomarkers Development, Validation and Application in Bladder Cancer
Arguente principal
|
Rui Pedro Monteiro Batista (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2019 | The role of RKIP in head and neck cancer
Arguente principal
|
Patricia Sofia Vaz da Cunha (Mestrado)
Universidade do Minho Escola de Medicina, Portugal
|
2019 | Serum VEGF levels in colorectal carcinoma : its relationship with clinicopathological characteristics and disease outcome
Arguente principal
|
Inês da Cunha Macedo Conde (Mestrado)
Universidade do Minho Escola de Medicina, Portugal
|
2019 | Telomere Biology of Cutaneous T-cell Lymphomas
Arguente principal
|
Joana Ropio (Doutoramento)
Université de Bordeaux, França
|
2019 | Regulation of glucose uptake in mammalian cells by protein phosphorylation networks
Arguente principal
|
Andreia Filipa Almeida Henriques (Doutoramento)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
2018 | TERT promoter mutations in cancer: from cell immortalization to invasion?
Arguente principal
|
Ana Cristina Afonseca Pestana (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
|
2018 | Extracellular Matrix-Glycan Dynamics in Gastric Cancer
Arguente principal
|
Mariana Cristina Nogueira Ferreira (Mestrado)
Universidade do Minho, Portugal
|
2018 | Evaluation of the role of LRP1B in the response of human ovarian cancer cells to liposomal doxorubicin
Arguente principal
|
Inês de Andrade Matos Gonçalves Saraiva (Mestrado)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
|
2018 | Exploring characteristics of atypical cancer cells from the HT29 human colonic adenocarcinoma cell line
Arguente principal
|
Maria Ine^s de Castro Silva (Mestrado)
Universidade do Porto Faculdade de Medicina, Portugal
|
2018 | Urothelial Bladder Cancer and Chemoresistence: Role of Energetic Metabolism Reprogramming
Arguente principal
|
Joana Moutinho Lopes Martins (Mestrado)
Universidade do Minho Escola de Medicina, Portugal
|
2018 | SPINT2 expression in lung cancer
Arguente principal
|
Bruno Daniel Oliveira Peixoto (Mestrado)
Universidade do Minho Escola de Medicina, Portugal
|
2017 | Role of Mitochondrial Dynamics in Hu¨rthle Cell Tumors: Coupling, Uncoupling and Fission
Arguente principal
|
Liliana Pereira Santos (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2017 | Evidence for a role of autophagy in the release of extracellular vesicles by tumour cells: possible implications for drug
resistant cells with impaired autophagy
Arguente principal
|
Andre´ Figueiredo Pina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2017 | Delivery of methotrexate using fucoidan/chitosan pH sensitive nanoparticles
Arguente principal
|
Ana Isabel Ferreira Barbosa (Mestrado)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2015 | Joint Modelling of Longitudinal and Survival Data on Breast Cancer
Arguente principal
|
Ana Isabel Coelho Borges (Doutoramento)
Universidade do Minho Escola de Ciências, Portugal
|
2013 | First molecular and biochemical characterization of the extracellular matrix of Saccharomyces cerevisiae
Arguente principal
|
Fábio Luís Silva Faria Oliveira (Doutoramento)
Universidade do Minho Escola de Ciências, Portugal
|
2013 | Role of Monocarboxylate transporter in lung development and lung cancer
Arguente principal
|
Sara da Costa Granja (Doutoramento)
Universidade do Minho Escola de Medicina, Portugal
|
2012 | Unravelling the function and regulation of human NLZ1 and COG8/PDF
Arguente principal
|
Isabel Pereira de Castro (Doutoramento)
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
2011 | Functional characterization of purified vacuoles and evaluation of their role in yeast apoptosis induced by acetic acid
Arguente principal
|
Andreia Doris (Mestrado)
Universidade do Minho, Portugal
|
2010 | Study of the role of monocarboxylate transporters in colorectal carcinoma
Arguente principal
|
Helena Pereira (Mestrado)
Universidade do Minho, Portugal
|
2010 | The importance of H-RAS 81T-C polymorphism in cellular behaviour
Arguente principal
|
Mariline Mendes Silva (Mestrado)
Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
|
2009 | Nanotecnología en Biomedicina: evaluación de la biocompatibilidad de nanoestructuras y su aplicación en el desarrollo de vacunas
y biosensores
Arguente principal
|
Belén Díaz Freitas (Doutoramento)
Universidade de Vigo, Espanha
|
2008 | Caracterização da P149: uma nova proteína humana que interage com membros da via Wnt
Arguente principal
|
Isabel Pereira Castro (Mestrado)
Universidade do Porto Faculdade de Medicina, Portugal
|
Arbitragem científica em revista
Nome da revista (ISSN) | Editora | |
---|---|---|
2018 - Atual | Guest editor da revista “Cells” no “Special Issue”: "Role of KRAS in Colorectal Cancer", since 2018. | MDPI |
2017 - Atual | Associate guest editor for Clinical Nutrition in the journal Frontiers in Nutrition | Frontiers |
2017 - Atual | Review Editor for Molecular Diagnostics and Therapeutics in Frontiers in Molecular Biosciences Journal, desde 2017 | Frontiers |
2020 - 2022 | Guest Associate Editor for Cancer Metabolism Frontiers in ONCOLOGY, TOPIC Editor on the Research Topic: “Annual Meeting of the International Society of Cancer Metabolism (ISCaM)- Cancer Metabolic Rewiring: Mapping the Road to Clinical Translation”, 2020-2022. | Frontiers |
2017 - 2018 | Topic editor of “Cancer Metabolism and Nutrition: Impact in Tumor Biology and Therapy” at Frontiers in Nutrition journal. 2017-2018. | Frontiers |
2014 - 2018 | Editorial Board as Review Editor of Frontiers in Molecular Biosciences- Molecular Diagnostics (specialty section of Frontiers in Molecular Biosciences), 2014-2018. | Frontiers |
2012 - 2016 | Member of the editorial board of the Science Publishing Group in the journal Science Journal of Clinical Medicine. | Science Publishing Group |
Comissão de avaliação
Descrição da atividade Tipo de assessoria |
Instituição / Organização | Entidade financiadora | |
---|---|---|---|
2024/01 - 2024/06 | Research Project evaluator for the “French National Cancer Institute (INCa) - PLBIO 2024”
Avaliador
|
Institut National du Cancer | |
2021/10/14 - 2021/10/15 | - Judging Panel and selection of abstracts to be presented as oral communications at the II ASPIC-ASEICA International Meeting
Current Trends in Precision Medicine in Cancer, online event.
Coordenador
|
Associação Portuguesa de Investigação em Cancro (ASPIC), Portugal | |
2021/10/14 - 2021/10/15 | - Judging panel for the best oral presentations at the II ASPIC-ASEICA International Meeting Current Trends in Precision Medicine
in Cancer, online event.
Coordenador
|
Associação Portuguesa de Investigação em Cancro (ASPIC), Portugal | |
2016 - 2016 | Evaluation and selection of abstracts to be presented as oral or poster presentations at the 2nd International Congress of
Associação Portuguesa de Investigação em Cancro (ASPIC).
Avaliador
|
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal | |
2016 - 2016 | Evaluation Jury of the prizes for the best oral communications presented at the 2nd International Congress of Associação Portuguesa de Investigação em Cancro (ASPIC), IPO, Porto. | Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal | |
2015/09 - 2015/11 | Jury at the contest "Eureka! - Concurso Nacional de Ciência", which took place for the first time between September and November
2015. The main aim of the project is to present and discuss scientific topics, based on a creative, innovative and entrepreneurial
spirit. It is aimed at all students enrolled in a higher education institution in Portugal (university and polytechnic).
Avaliador
|
||
2014 - 2014 | Evaluation jury of projects of Fonds National de la Recherche (FNR) Award for Outstanding Scientific Publications | ||
2014 - 2014 | Competition for Research Projects Gabinete de Apoio à Investigação (GAI), to promote an internal contest to promote a basic
and clinical investigation to be carried out within FMUC. The jury panel was published, simultaneously with the awarded,
by all the scientific community of FMUC and published at the GAI website (http://www.uc.pt/fmuc/gai).
Avaliador
|
Universidade de Coimbra Faculdade de Medicina, Portugal | |
2012 - 2012 | Reviewer and evaluator of abstracts to be accepted at the I Simposio Internacional de Enseñanza de las Ciencias http://webs.uvigo.es/isiec2012/
Avaliador
|
Universidade de Vigo, Espanha | |
2009 - 2009 | Evaluating Jury of projects for PhD grants in the Program Aides à la Formation-Recherche (AFR) of the Fonds National de la Recherche (FNR) from Luxembourg. |
Consultoria / Parecer
Descrição da atividade | Instituição / Organização | |
---|---|---|
2013 - 2020 | Unpaid consultancy activity as the Responsible Pharmacist (professional license no. 10931) at INFARMED for the import, maintenance and conservation of Narcotics / Psychotropic Substances as part of the project: "Prenatal stress and reward deficits: searching for the neurobiological underpinnings", which is taking place at the School of Medicine, ICVS/3Bs. The activity schedule has been set at 1 hour per month. | Infarmed Autoridade Nacional do Medicamento e Produtos de Saúde IP Centro de Documentação Técnica e Científica, Portugal |
Curso / Disciplina lecionado
Disciplina | Curso (Tipo) | Instituição / Organização | |
---|---|---|---|
2016 - Atual | Guest lecturer in the Postgraduate Course ONCOBIOLOGY, Doctoral Program in Biological Sciences Applied to Health, Department of Sciences, IUCS Instituto Universitário de Ciências da Saúde, CESPU with the title: Cancer definition and Hallmarks; Gandra, Paredes. | Programa Doutoral em Ciências Biológicas Aplicadas à Saúde (Pós-Graduação) | Cooperativa de Ensino Superior Politécnico e Universitário, Portugal |
2009/09 - Atual | Career Assistant Professor of the Departamento de Biologia da Universidade do Minho. | ||
2003 - Atual | Guest lecturer in the Oncobiology module of the PhD Program GABBA (Programa Graduado em Áreas de Biologia Básica e Aplicada) | Oncobiology (Doutoramento) | Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal |
2022/04/25 - 2022/05/06 | Organiser and coordinator of the advanced course "Cancer therapy: from basic research to clinic" | (Outros) | Universidade do Minho, Portugal |
2021/11/02 - 2021/11/02 | Lecturer in the Course Unit: MOLECULAR BASES OF CANCER AND THERAPEUTIC PRINCIPLES, 2nd year Integrated Master's Degree in Medicine, entitled "How yeast and cancer cells link-up to study colorectal cancer", UMinho, School of Medicine, Braga. | Mestrado Integrado em Medicina (Mestrado) | Universidade do Minho Escola de Medicina, Portugal |
2013 - 2014 | Guest lecturer for the postgraduate course: "Fundamentals in Genetics, Development and Neoplasia" entitled: "Cell Signaling: Signal Transduction in Cancer" ICVS, Escola de Ciências da Saúde, Universidade do Minho. | Fundamentals in Genetics, Development and Neoplasia (Pós-Graduação) | Universidade do Minho Escola de Medicina, Portugal |
2013/07/05 - 2013/07/05 | - Guest lecturer in the postgraduate course : "Pharmacological Development: from Organic Synthesis to Clinical Trials", entitled: ¿"New therapeutic approaches for colorectal cancer: the role of small chain fatty acids and oncogene KRAS." ¿ICVS. | Pharmacological Development: from Organic Synthesis to Clinical Trials (Pós-Graduação) | Universidade do Minho Escola de Medicina, Portugal Laboratório Associado ICVS 3B's, Portugal |
2013/07/05 - 2013/07/05 | Guest lecturer in the Postgraduate course: "Pharmacological Development: from Organic Synthesis to Clinical Trials", entitled: ¿New therapeutic approaches for colorectal cancer: the role of small chain fatty acids and oncogene KRAS. ¿ICVS | Fundamentals of Genetics, Development and Neoplasia (Pós-Graduação) | Universidade do Minho Escola de Ciências, Portugal Laboratório Associado ICVS 3B's, Portugal |
2007 - 2009 | Professor of Cell Biology of the Bachelor in Biochemistry and of Bioenergetics and Metabolism of the Bachelor in Biology/Geology. Teacher of practical classes in Animal Physiology and Bioenergetics and Metabolism of the Bachelor in Applied Biology and of Molecular Biology of the Bachelor in Biology/Geology. | Bachelor in Biochemistry, Bachelor in Biology/Geology, Bachelor in Applied Biology (Licenciatura) | Universidade do Minho, Portugal |
2008/06/26 - 2008/07/01 | Coordinator of the course Genetics and Molecular Biology II: From the Gene to the Cell.... Training course accredited by the Training Center of the Order of Biologists. Departamento de Biologia, Universidade do Minho. | (Pós-Graduação) | Universidade do Minho Departamento de Biologia, Portugal |
2004 - 2007 | Lecturer in Pharmacology for the Bachelor in Nursing, Toxicology for the Bachelor in Pharmacy Technician and Pharmacotoxicology for the Bachelor inClinical Analysis Technician. | Nursing (Licenciatura) | Instituto Superior de Saúde, Portugal |
2006 - 2006 | Lecturer in the postgraduation course "Introduction to Molecular Medicine and Cancer" organized by IPATIMUP. | (Pós-Graduação) | Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal |
2004 - 2004 | Guest lecturer in the Molecular Pathology module of the postgraduate course in Biomedicine at Faculdade de Medicina da Universidade de Coimbra. | Universidade de Coimbra, Portugal | |
1996 - 1997 | Monitor of laboratory classes in Molecular Genetics and Immunology, taught by Professor Anabela Cordeiro da Silva, in Departamento de Bioquímica da Faculdade de Farmácia da Universidade do Porto. | (Mestrado) | Universidade do Porto Faculdade de Farmácia, Portugal |
Entrevista (jornal / revista)
Descrição da atividade | Jornal / Forum | |
---|---|---|
2016/10/09 | News item in Observador on the Nobel Prize in Medicine: ¿Como o Nobel da Medicina chegou a uma sala de aula portuguesa¿ on the subject of autophagy in colorectal cancer, an area of research in which he has been working since 2008. | Observador |
Revisão ad hoc de artigos em revista
Nome da revista (ISSN) | Editora | |
---|---|---|
2021 - Atual | Cancers | MDPI |
2018 - Atual | Cells | MDPI |
2017 - Atual | Frontiers in Nutrition | Frontiers |
2022 - 2022 | International Journal of Molecular Sciences | MDPI |
2020 - 2022 | Frontiers in Oncology - Cancer Metabolism | Frontiers |
2021 - 2021 | Food and Function | The Royal Society of Chemistry |
2021 - 2021 | Journal of Experimental & Clinical Cancer Research | BMC |
2021 - 2021 | Frontiers in Cell and Developmental Biology | Frontiers |
2021 - 2021 | Scientific reports | Nature |
2021 - 2021 | Seminars in Cancer Biology | Elsevier |
2017 - 2020 | Frontiers in Nutrition | Frontiers |
2019 - 2019 | Ageing | Oxford Academic |
2018 - 2018 | International Journal of Molecular Sciences (1422-0067) | MDPI AG |
2018 - 2018 | Biochimie | Elsevier |
2018 - 2018 | RSC Advances (2046-2069) | The Royal Society of Chemistry |
2018 - 2018 | Anti-Cancer Agents in Medicinal Chemistry (1871-5206) | Bentham Science |
2017 - 2017 | Food & Function (2042-650X) | The Royal Society of Chemistry |
2017 - 2017 | Journal of Experimental & Clinical Cancer Research | Springer Nature |
2017 - 2017 | Molecular Diagnostics and Therapeutics | Frontiers |
2016 - 2017 | Cell Death and Disease | Springer Nature |
2016 - 2016 | PLoS ONE (1932-6203) | Public Library of Science |
2015 - 2016 | Oncotarget | Oncotarget |
2013 - 2016 | Carcinogenesis | Oxford Academic |
2012 - 2015 | Cancer Research Journal | Science Publishing Group |
2014 - 2014 | Journal of Clinical Endocrinology and Metabolism | Oxford Academic |
2014 - 2014 | BMC Cancer | Springer |
2014 - 2014 | Frontiers in Molecular Biosciences- Molecular Diagnostics (2327-2724) | Science Publishing Group |
2012 - 2014 | International Journal of Nutrition and Food Sciences (2327-2694) | Science Publishing Group |
2013 - 2013 | European Journal of Human Genetics (1476-5438) | Springer Science and Business Media LLC |
2013 - 2013 | Biological Trace Element Research | Springer |
2012 - 2012 | Science Journal of Clinical Medicine (2327-2724) | Science Publishing Group |
2010 - 2010 | BMC Cancer | Springer |
2008 - 2008 | BMC Cancer (1471-2407) | Springer (Biomed Central Ltd.) |
2008 - 2008 | Journal of Pathology | Wiley Online Library |
2007 - 2007 | Oncogene (0950-9232) | Springer Science and Business Media LLC |
2006 - 2007 | Virchows Archiv (1432-2307) | Springer-Verlag |
2006 - 2006 | Molecular and Celular Biology | ASM Journals |
2006 - 2006 | Endocrine Pathology | Springer |
2006 - 2006 | Molecular & Cellular Biology (2372-3556) | Landes Bioscience |
Distinções
Prémio
2022 | "ASPIC Patients' Advocacy Award"
Associação Portuguesa de Investigação em Cancro (ASPIC), Portugal
|
2020 | Prize for the best poster in the conference Cancer Biology: from basic to translational research
Liga Portuguesa Contra o Cancro, Portugal
|
2015 | "SBBq Award" for the best poster presented during the 44th Annual Meeting of Brazilian Society for Biochemistry and Molecular
Biology and 23rd International Congress of International Union of Biochemistry and Molecular Biology
Sociedade Brasileira de Bioquímica e Biologia Molecular, Brasil
|
2014 | Award for the best Poster at the "II Symposium of the PhD Programme on Molecular and Environmental Biology”, with the title: The cytotoxicity of 3-Bromopyruvate in breast cancer cells depends on extracellular pH, João Azevedo-Silva |
2013 | Award for the best scientific work at the Conference - Faraday Discussion 166: Self-Assembly of Biopolymers - University
of Bristol ,UK: Eugénia Nogueira, Ana Preto, Artur Cavaco-Paulo.
Royal Society of Chemistry, Reino Unido
|
2012 | Tribute to research groups in Portugal that investigate breast cancer and publish in indexed journals |
2004 | Best Scientific Work 2004 award for PhD thesis
Centro de Genética Médica Doutor Jacinto Magalhães, Portugal
|
2003 | Award for the Best Communication in Biomedical Sciences
Sociedade Portuguesa de Ciências Farmacêuticas, Portugal
|
Outra distinção
2018 | Bolsa de sabática- Universidade de Vigo, CINBIO. INSTITUIÇÃO DE DESTINO: UNIVERSIDADE DE VIGO DEPARTAMENTO: CENTRO DE INVESTIGACIÓNS BIOMÉDICAS (CINBIO). |